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Phylogenetic analysis plays a crucial role in quality control in the HIV drug resistance testing
laboratory. If previous patient sequence data is available sample swaps can be detected
and investigated. As Antiretroviral treatment coverage is increasing in many developing
countries, so is the need for HIV drug resistance testing. In countries with multiple lan-
guages, transcription errors are easily made with patient identifiers. Here a self-contained
blastn integrated phylogenetic pipeline can be especially useful. Even though our pipeline
can run on any unix based system, a Raspberry Pi 3 is used here as a very affordable and
integrated solution.
Performance benchmarks
The computational capability of this single board computer is demonstrated as well as the
utility thereof in the HIV drug resistance laboratory. Benchmarking analysis against a large
public database shows excellent time performance with minimal user intervention. This
pipeline also contains utilities to find previous sequences as well as phylogenetic analysis
and a graphical sequence mapping utility against the pol area of the HIV HXB2 reference
genome. Sequence data from the Los Alamos HIV database was analyzed for inter- and
intra-patient diversity and logistic regression was conducted on the calculated genetic dis-
tances. These findings show that allowable clustering and genetic distance between viral
sequences from different patients is very dependent on subtype as well as the area of the
viral genome being analyzed.
Availability
The Raspberry Pi image for PhyloPi, source code of the pipeline, sequence data, bash-,
python- and R-scripts for the logistic regression, benchmarking as well as helper scripts are
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Introduction
The use of combined Antiretroviral Therapy (cART) has dramatically decreased the mortality
and morbidity of HIV infected people. It was estimated that 12.9 million people were receiving
antiretroviral treatment (ART) by the end of 2013 worldwide. The number of HIV infected
individuals not receiving ART dropped from 90% in 2006 to 63% in 2013 globally [1]. Since
2010 the number of people living with HIV on antiretroviral therapy increased from 7.5 mil-
lion to 17 million in 2015, whereas people infected with HIV only increased from 33.3 million
to 36.7 million in the same time period [2]. However, inadequate adherence on ART, especially
when low genetic barrier regimens such as NNRTI-based combination therapies are pre-
scribed, often results in virologic failure with the emergence of drug resistance. In contrast, in
cases with virologic failure of high genetic barrier regimens, such as boosted protease inhibi-
tor- or dolutegravir- containing regimens drug resistance is often absent [2,3]. Drug resistance
testing can differentiate patients, with persisting failure, who require adherence support from
those who require a regimen switch and to select appropriate third-line regimens [4,5]. It has
been demonstrated by numerous investigators that not only is drug resistance on the rise in
South Africa and other countries, but that transmitted resistance is also on the increase[2,6–
10]. As a result, this will increase the amount of sequence data which will become available.
We believe the work done here can help individual drug resistance facilities to cope with the
quality assurance requirements this increase will infer.
Phylogenetic analysis is typically used in molecular HIV drug resistance testing facilities to
detect gross cross contamination during nucleic acid extraction, reverse transcription, poly-
merase chain reaction or sequencing. In some cases, samples swaps can be detected if the
patient has more than one viral sequence. However, in busy clinics and diagnostic facilities
transcription errors can be made and errors are introduced in patient identification informa-
tion, like names and date of birth. Also, from experience in our South African setting, patients
can have multiple names which can be used interchangeably based on the ethnicity and lan-
guage preference of the healthcare worker/patient pair. This makes it difficult and laborious to
find previous viral sequences to use in phylogenetic analysis. Our pipeline includes a self-
updating blast database which is used to find most similar past sequences to include in the phy-
logenic analysis.
Although, the comparison of current and past viral sequences does not guarantee that no
sample swaps occurred, it does offer a valuable screen. The ability to include previous isolates
in the drug resistance genotypic inference provides the resistance mutation history of the
patient. It is probable that after treatment changes the circulating viral population changed
and previous resistance mutations have reverted or have been displaced by wild type amino
acid [11,12]. The archived proviral resistance can become important when formulating a 3rd
line treatment regimen in most third world settings.
Phylogenetic inference can be broken down into 4 consecutive steps [13]. The first step is a
multiple alignment of sequences. This alignment is then curated, especially to look for and
exclude alignment overhangs and in some cases gaps. This can dramatically improve the
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accuracy of the phylogenetic inference [14]. The curated alignment is then used as the input
data for phylogenetic analysis and the phylogenetic tree is finally rendered. Combining these
steps into an automated pipeline has opened phylogenetic analysis to the non-specialist and
has created a convenient solution even for the specialist. This is very well demonstrated by the
popular Phylogeny.fr web server, available at http://www.phylogeny.fr/index.cgi [13]. Also, the
plethora of software available to conduct phylogenetic analysis can be daunting to the casual
user as can be appreciated from Felsentein’s inventory available at http://evolution.genetics.
washington.edu/phylip/software.html. Another very well cited and freely available software
package for phylogenetic analysis is Mega [15]. The one thing which these ‘Swiss army knife’
implementations have in common is that already well-established and -cited software or algo-
rithms are used to conduct the various steps. We demonstrate a purpose build, ultra-low cost,
self-contained and portable solution to phylogenetic inference in the HIV drug resistance gen-
otyping laboratory. Our pipeline is implemented on a Raspberry Pi 3. These pocket sized single
board computers are the brain child of Eben Upton and colleagues form the Cambridge Uni-
versity Computer Laboratory [16]. We furthermore conducted logistic regression on publically
available HIV sequence data from the Los Alamos HIV sequence database in order to demon-
strate the variations between inter- and intra-patient genetic distances.
Usage and general description
When powered on, PhyloPi broadcasts a WiFi hotspot to which another device can connect. It
serves a simple web interface which is used as a graphical user front end. Here the user can set
up the initial BLAST [17,18] database by formating a blastn database from a cumulative fasta
file of all viral sequences sequencing data done previous. This requires the user to click on the
“BLASTdb conf” button which then takes the user to the blast database setup page. Here the
user uses the “Browse. . .” button to select the fasta file to be formatted into a blastn database.
The user supplies a name for the database and click on “Format DB”. After this initial step the
BLAST database gets updated every time the user submits new sequences for analysis, thus
maintaining a rolling, up to date database. Before uploading the fasta file for phylogenetic
inference, the user can choose how many most similar sequences from the BLAST sequence
database must be included for analysis.
The result for every analysis is stored in a SQL database which makes it possible to retrieve
previous analysis as a compressed archive.
These past results can either be queried by a query sample used in the analysis, the subject
sample found by blastn in any specific analysis or by name of the analysis. If all fields are left
empty, all previous analyses will be listed. Every step of the pipeline is stored in a compressed
result folder which allows the user to intervene on the phylogenetic inference from any step
and to inspect each step. The phylogenetic tree rendering is available in portable network
graphics (PNG) format, scalable vector graphics (SVG) format and portable document format
(PDF). Also included in the result folder is a HTML R rendered heatmap showing the isolates
in a distance matrix. This distance matrix is also available as a comma separated values file.
Other files in the results folder include a fasta file containing the query sequences submitted
for analysis combined with the subject samples retrieved by blastn, as well as the MAFFT [19]
aligned fasta files pre and post TrimAl [14] curation. TrimAl also outputs a HTML file which
annotates its actions on the MAFFT alignment; this is also included in the results archive.
The user can search for previous isolates by entering a comma separated list of full or par-
tially matched identifiers depending and how they set a check box. This makes it easy to
retrieve previous samples in case the user is interested in the resistance profile of the previous
isolates.
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Also, a ‘sanity check’ has been implemented which the user can use to determine if the
input sequences are suitable for phylogenetic inference, or more generally are the sequences
capable of generating a sensible alignment. It is conceivable, that in a busy drug resistance test-
ing facility, the user might end up with sequences in a file which cover areas of the HIV
genome which does not overlap. PhyloPi will not be able to handle such data and will fail after
the TrimAl step. In such instance, PhyloPi warns the user about this and the offending
sequence identifier is displayed in red. The ‘sanity check’ provides a crude way of mapping the
individual entries in the fasta file to the POL region of HXB2 (Fig 1) which is available as one
of the links on the results page. The ‘sanity check’ is also available as a separate mapping only
tool through the link provided on the main page. Since blastn is already available in PhyloPi, it
was used for the mapping against the HXB2 reference. From Fig 1, it is easy to find the
sequences not suitable for inclusion in the phylogenetic inference by PhyloPi or any software.
The sequence covering the protease only region cannot produce a sensible alignment with the
sequences covering the reverse transcriptase only. A sequence covering the integrase area was
Fig 1. A graphical representation of input sequences mapped against the reference, HXB2. The legend bar at the
bottom shows the protease, reverse transcriptase and integrase in green, blue and red respectively. It is clear from this
that the selected sequences do not qualify for phylogenetic inference.
https://doi.org/10.1371/journal.pone.0213241.g001
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also included for illustrative purposes. This graphic is rendered in SVG format, thus allowing
very high resolution. This is important if the user has a fasta file with many entries. We have
tested this on 105 sequences and were able to zoom in and quickly find sequences not making
sense in the alignment.
Considerations on software implemented
When choosing software for this pipeline the following factors were considered. The source
code of the software must be available to allow for compilation. This is essential in order to
obtain binary executables capable of running on the Raspberry Pi 3 ARM Cortex-A53 proces-
sor. The openness and availability of source code also provides transparency and the possibility
of scrutiny, thus no ‘black boxes’. Since the Raspberry Pi 3 has only 1 GB of random access
memory, the software used must have a lightweight memory footprint. For the computation-
ally intensive tasks we selected software capable of parallelizing in order to maximize the use of
the ARM Cortex-A53 quad core processor. Lastly, we only used well cited software with a com-
mand line interface.
The pipeline
When the user uploads a new fasta file for analyses our pipeline first determines whether any
unique entries were uploaded not yet present in the master fasta file. If a unique header is
found in the fasta entry then that sequence is added to the master fasta file. Thus, if two or
more sequences are identical, but the headers differ they will be added to the master fasta file.
After new sequences have been added to the master fasta file, it gets formatted to a nucleic acid
BLAST database with makeblastdb [18]. This updated BLAST database can now be used to
retrieve the most relevant sequences for the analysis. In case different sequences as queries
retrieve the same result sequence, these duplicates are removed. This combined input and
blast retrieved sequences are saved as a fasta file which is used as the input for the multiple
sequence alignment. The alignment is conducted using MAFFT [19], this is followed by
removal of overhangs in the multiple sequence alignment using TrimAl [14]. The phylogenetic
inference is conducted by FastTree 2 [20] and finally the ETE3 Python API (Application Pro-
gram Interface) is used for tree rendering [21]. A block diagram of the PhyloPi pipeline is illus-
trated in Fig 2. The R programming language is used to calculate the genetic distances from
the MAFFT aligned multiple sequence alignment using the packages seqinr and APE [22,23].
The heatmap is available in a comma separated values file as well as an interactive HTML
file with colours corresponding to the genetic distances. The blocks of the heatmap are shaded
from green to yellow to red and provide information such as sequence identifiers and genetic
distances. The heatmap gives additional support to find close clustering of sequences. The
heatmap colours are scaled such that closely related isolates are coloured red and distant
related isolated are coloured green. This interactive HTML heatmap is rendered using the
plotly R package.
As can be seen from Fig 2, the entire pipeline is completely self-contained and the only
additional requirement is a WiFi capable device to be used for input. This provides extra secu-
rity, in that the data is not available on the internet. Other noteworthy software used are
shown in Table 1.
Application of PhyloPi in the HIV drug resistance testing laboratory
The HIV genotyping drug resistance facility at Department of Medical Microbiology and
Virology, University of the Free State / National Health Laboratory Services has been using the
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PhyloPi pipeline for approximately a year. The following case reports are examples of applica-
tions of the PhyloPi in this facility where situations were resolved using this tool.
Fig 2. A block diagram illustrating the PhyloPi pipeline. A web interface offers control over the pipeline. With each sequence submission the master fasta file
is updated and a BLAST database is formatted, thus maintaining a rolling blastn database. Duplicate entries are removed from the combined input and BLAST
retrieved isolates and this is aligned with MAFFT. Overhangs are removed from the alignment before phylogenetic inference with FastTree. Finally, the tree is
rendered with ETE3.
https://doi.org/10.1371/journal.pone.0213241.g002
Table 1. Other software used for PhyloPi.
Software Use/Purpose Link to software
Hostapd and
udhcpd
WiFi hotspot and DHCP server. Enables devices to connect to PhyloPi. https://w1.fi/hostapd/
and
https://udhcp.busybox.net/
Lighttpd 1.4.35 Web server. https://www.lighttpd.net/
SQLite 2.8.17 SQL database engine. To store results. https://www.sqlite.org/
R 3.3.3 R https://www.r-project.org
Open MPI Message Passing Interface for mutli threading. https://www.open-mpi.org/
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Case 1. A sample for a HIV drug resistance test was processed and released for patient A
(adult female) without any quality control problems. About a month and a half later a sample
from the same clinic was processed for patient B. Our analysis with PhyloPi revealed a genetic
distance of 0 between patient A and B. The requesting clinician was contacted and the situa-
tion explained. The clinician reported that patient A was seen at the clinic while patient B’s
folder was still on the desk after review. When a nurse fetched patient A for phlebotomy the
wrong file (that of patient B) was taken as the file for patient A, thus the identity of patient B
was used for patient A on the sample. If only per-batch phylogenetic analysis were performed
here, this mistake would have been missed.
Case 2. A sample was processed for HIV drug resistance testing before the viral load
which was taken on the same day was available. When the viral load became available it was
<150 RNA copies/mL. The HIV drug resistance sample was resubmitted for viral load testing
to exclude a sample swap during viral load testing; the same viral load result was however
reported. Analysis with PhyloPi revealed a genetic distance of 0.006 in the genetic distance
heatmap with a sample processed approximately 9 months earlier. Even though the name of
the patient was spelled differently, the date of birth matched as well as the address. We thus
concluded both samples belonged to the same patient.
Vertical transmission and archived resistance. Also, mother and child pairs can be
found with PhyloPi. Although this does not have obvious significant clinical meaning it
does show that the pipeline works. In cases where patients have been genotyped before, it is
possible that the patient’s viral population has lost drug resistance mutations due to the lack
of selective pressure because of regimen changes. Here it can become important to include
previous results, as it will give the clinician an idea of the archived drug resistance. Either
way, PhyloPi reliably detects previously samples from same patients or mother to child
transfer.
Performance benchmarks
In order to demonstrate the capability of this small single board computer we performed
benchmarks in terms of the time each step in the pipeline takes. Instead of using CPU time to
illustrate the performance of the software used, we rather gathered the real time required to
complete each step. Thereby we show the time requirements in relevance to the workings of
the laboratory.
We downloaded HIV-1 sequences of the POL CDS region from the Los Alamos HIV public
database (http://www.hiv.lanl.gov/). At the time of this analysis, 11 337 sequences were avail-
able. A descriptive summary of the sequence lengths used for this benchmarking is illustrated
in Table 2. For this analysis we used the Python bindings for the Selenium WebDriver API. In
short, our test script, pseudo-randomly selected sequences from the above mentioned fasta
file. The number of sequences selected was incremented by one sequence at time, in a loop
ranging from 1 to 50. The Selenium WebDriver was used for fasta selections through the Phy-
loPi web interface the same way a human would have done. Timestamps were taken at each
step in the pipeline and this data was used to produce Fig 3 and Table 3. Using a python script,
we have pseudo-randomly selected sequences described in Table 2 for benchmark analysis for
creating the blastn database. Linear regression of the time taken against the number of samples
Table 2. Descriptive summary of the sequence lengths from the Los Alamos database used for benchmarking.
Min 1st Quartile Median Mean 3rd Quartile Max
1764 3003 3012 3010 3012 3176
https://doi.org/10.1371/journal.pone.0213241.t002
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Fig 3. Regression analysis of benchmarking PhyloPi on the Los Alamos HIV sequences. (a) The number of sequences retrieved
by BLAST vs. the number of input (query) sequences. (b) Time (s) vs. the number of input (query) sequences. (c) Time (s) vs. the
number of sequences included by BLAST, thus the total number of sequences in the alignment. (d) Time (s) for phylogenetic
inference with FastTree vs. the total number of sequences in the alignment.
https://doi.org/10.1371/journal.pone.0213241.g003
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has a slope of 0.0009 seconds per sequence. All the code for the analysis is available in the git
repository.
From all the steps in our pipeline the time requirements for the most time-consuming steps
are plotted in Fig 3. All but the alignment step has a linear relationship of time required vs.
number of sequences. The multiple sequence alignment has a near quadratic relation (Fig 3C)
as can be expected. FastTree2 on the other hand, employs heuristics to change the O(N2) prob-
lem to a O(N) problem, thus the linearity illustrated in Fig 3D [20].
Many genotyping laboratories are confined to 96 well plates for the sequencing reactions
and most use 2 or 3 times coverage of the area of interest. This means that most laboratories
will be able to fit 16 or 24 patient samples on a plate considering the target for genotyping is
the protease and reverse transcriptase drug resistance relevant area. In our analysis we have
included the whole POL coding region which is thus an overestimation. However, including
the 5 best blastn retrieved sequences in our analysis we can demonstrate the time requirements
for 24 sequences as shown in Table 3.
It is worth mentioning that implementing a combined protease, reverse transcriptase as
well as integrase resistance testing assay is possible. This would however require more
sequencing primers and reduce the number of patient samples being processed per 96 well
plate. Due to the way sequences are retrieved by blastn, our pipeline can handle mixed
sequences in the BLAST database. Most laboratories perform a combined protease and reverse
transcriptase assay and only do an integrase assay on patients exposed to integrase inhibitors.
It is necessary however, to submit queries of different areas separately, i.e. the sequences being
submitted for analysis should be capable of producing a sensible alignment. Thus, if a query
containing integrase sequences is submitted, blastn will retrieve only sequences of integrase.
Inter- and intra-patient genetic distances of important coding regions
To gauge inter- and intra-patient variability and how to display this in a colour scaled heatmap
we again examined sequences from the Los Alamos HIV database. In short, to look at inter-
and intra-patient genetic distances of HIV isolates, sequences for the protease and reverse
transcriptase coding regions, as a combined sequence (PR_RT), and sequences for the inte-
grase genes were downloaded for the two subtypes, B and C, separately. The fasta files for the 2
subtypes were parsed with python scripts. One script was used to keep only one sequence per
Table 3. Time requirements for the various steps in the PhyloPi pipeline.
Step (Software) N query sequences N Total sequences Time (mm:ss)
Retrieving related sequences (blastn) 24 110 04:24
MSA (MAFFT) NA 110 21:11
Phylogenetic inference (FastTree) NA 110 01:12
All other steps combined NA 110 00:27
Total time NA 110 27:14
https://doi.org/10.1371/journal.pone.0213241.t003
Table 4. Breakdown of sequences used in the inter- and intra-patient genetic distance analysis.
Subtype Coding region Type Inter Type Intra
B PR_RT 1969 sequences 359 sequence clusters
INT 2461 sequences 405 sequence clusters
C PR_RT 1753 sequences 455 sequence clusters
INT 1171 sequences 217 sequence clusters
https://doi.org/10.1371/journal.pone.0213241.t004
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patient while another python script was used to put sequences from same patients in to sepa-
rate fasta files; which we refer to here as patient clusters. This inter- and intra-patient filtering
was done based on the Los Alamos HIVdb ‘Patient id’. Any sequence where this data was not
available was excluded from the analysis. The inter-patient fasta files were aligned as one file,
while the intra-patient clusters were aligned separately by using a bash script; again, with
MAFFT as aligner. A breakdown of the number of sequences and patient clusters is shown in
Table 4. As for the phylogenetic inference, for the genetic distance calculations the K80 [24]
substitution model was used. The genetic distances from all the clusters were calculated with
seqinr and ape as described above.
The violin plots (Fig 4A) shows overlap between types inter- and intra-patient for both sub-
types and for both the integrase (INT) as well as the protease reverse transcriptase (PR_RT)
coding regions. From the violin plots, it is clear that for type inter-patient the INT coding
region is more conserved than the PR_RT coding region.
Logistic regression was performed using the R glm library and modeled results are plotted
in Fig 4B. From this it is clear that subtype B is more conserved compared to subtype C for the
coding regions analyzed here. Also, the INT part of the POL gene for both subtypes is more
conserved compared to the PR_RT part of the POL gene. Our findings here are in agreement
with[25], who have found that the integrase protein sequence is the most conserved among the
15 proteins they analyzed followed by the rest of the viral enzymes. Comparing the distance
intercepts for a predicted probability of 0.5 for either type inter or intra, we can see there is a
noticeable difference between subtypes and coding regions. Thus, from the results shown in
Fig 4, it is difficult to select one genetic distance cutoff that will fit all subtypes and coding
regions. It is also conceivable that the probability of finding transmission clusters will increase
as the blastn database increases.
Discussion
We have demonstrated that this affordable single board computer is capable of performing
phylogenetic inference in an impressive short time and is capable of retrieving the most signifi-
cant sequences from its automatically maintained blastn database without requiring any addi-
tional user intervention. Also, the utility of this self-contained pipeline was shown in our case
studies. Additionally, PhyloPi provides a search interface for retrieving sequences by name as
well as past analysis stored in a SQL database. PhyloPi also provides a tool with which the user
can easily map sequences in a fasta file against HIV HXB2 using blastn. This quickly gives a
result showing the areas the sequences cover in the POL region, which can be useful to deter-
mine whether input sequences are suitable for alignment.
Currently PhyloPi approximates maximum likelihood phylogenetic inference using the
K80 (Kimura 80) model [24]. This model assumes equal base frequencies, but different
rates of transitions vs. transversions. It is very difficult to have an optimal model if the
area of the HIV pol gene submitted for phylogenetic inference can change as well as differ-
ences in sample batches. Rather than overfitting the data by using too many parameters
we use this simple two parameter model. The downside of this, however, is the overesti-
mation of branch lengths. As illustrated in our case studies, PhyloPi were still successful
in flagging inspection of sequence results which could then be resolved by further investi-
gation. It is also worth mentioning that all the intermediate files leading to the final result
are available for each analysis. The user can intervene at any step. A laboratory might
want to validate the use a PhyloPi by using the blastn combined results using their current
methods or the already trimmed alignment file for phylogenetic inference using their pre-
ferred selection of software and model.
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We do not suggest using PhyloPi for finding transmission clusters; rather if two seemingly
unrelated patients’ have viral sequences which cluster close together it is possible that the virus
was transmitted from one patient to the other, which explains the clustering rather than a con-
tamination issue. This becomes more likely as the blastn database grows.
The logistic regression showed that there is no clear cutoff between inter- and intra-patient
HIV sequences and that this is dependent on the subtype and area being sequenced. Further-
more, as the blastn database grows in size, the likelihood of finding closely related sequences
from different patients’ increases. There are different sources of sample contamination. Cross
contamination between samples may rather create an abnormally high number of mixed bases
in the resulting sequence and it is standard practice to repeat these samples. If a sample with a
very high viral load contaminated an adjacent sample or a sample in the same batch with a
very low viral load, this may not result in large numbers of mixed bases, but these samples will
rather have a genetic distance of zero or very close to it. Amplicon carryover contamination
could also either result in a high number of mixed bases or identical sequences that are clus-
tered together in time. The true power of PhyloPi is its ability to detect and trigger inspection
of sequencing results from patients where there is no apparent trigger for such investigation
from routine quality assurance or clinical information provided as illustrated in the section
‘Application of PhyloPi in the HIV drug resistance testing laboratory’, case 1. It is difficult
tracking patients in the health sector and especially so in resource limited settings. We typically
find patients with various different patient identifiers even when visiting the same health care
Fig 4. Genetic distance analysis of type inter and intra. (a) Genetic distances depicted in violin graphs of both subtype B and C for patient comparisons, type
intra and inter separately showing INT (integrase) and PR_RT (protease reverse transcriptase) coding regions. (b) Logistic regression models showing
predicted probability of sequences being of type inter or intra. A probability of one correlates strongly with type intra where a probability of zero strongly
correlates with type inter. The dotted lines show the distance intercepts of a 0.5 probability cut-off.
https://doi.org/10.1371/journal.pone.0213241.g004
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facility. Despite efforts from our Central Data Warehouse, it is difficult to match patient details
such as names, date of birth and address. Patients might use different names depending on lan-
guage preferences of the patient and health care provider. Furthermore, transcription errors
make this even worse. We have found multiple previous sequence results for patients which
we otherwise would not have detected. Human error is inevitable and any safety net to catch
these mistakes is worthwhile, PhyloPi provides such a safety net.
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